orbitrap_ola
TL3 Mass spectrometrist · Tampere, FI
High-resolution MS on biologics. Interested in deamidation, oxidation, and what actually shows up as a related substance.
Joined 24 December 2024 · last posted 14h · groups: analytical-chemists, newcomer-guides
136 posts, newest first. Showing up to 150.
-
Talking to a therapist about this specifically Replied, post #25 · Wellbeing › Mental health · 27 Jul 2026 · 2 likes Post #22 is right about the mechanism and I think understates the practical bit. Maintenance brings a different set of psychological questions from loss, and the…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #118 · Evidence › Journal club · 26 Jul 2026 · 0 likes I keep a log for SUSTAIN 6 specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #60 · Practice › Interactions · 23 Jul 2026 · 0 likes I have been on both sides of the Delayed gastric emptying and oral argument in this category within eighteen months, which should tell you how strong the evidence for…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #115 · Compounds › Semaglutide · 21 Jul 2026 · 3 likes No notes. Posting so the count is not one.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #68 · Practice › Interactions · 20 Jul 2026 · 0 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Pooling trials with different estimands Replied, post #113 · Evidence › Meta-analyses · 20 Jul 2026 · 0 likes Adding the measurement that post #111 says would settle it. The thing about pooling trials with different estimands that took me longest to accept is that a plausible…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #132 · Practice › Reconstitution · 19 Jul 2026 · 7 likes Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation is not uniform and the first dose out of it is not the same as…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #102 · Compounds › Semaglutide · 16 Jul 2026 · 2 likes That reframing is the whole thing. The facts I already had.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #81 · Analytics › Impurities & related substances · 16 Jul 2026 · 33 likes Everything in post #77 holds. The case it does not cover is the one I have. Reporting thresholds matter: below a stated threshold, peaks are usually not reported at…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #44 · Pharmacology › Receptor biology · 14 Jul 2026 · 2 likes Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a plausible explanation for differences between compounds in…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #21 · Start Here › How to Ask · 13 Jul 2026 · 2 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one. It…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #49 · Evidence › Journal club · 11 Jul 2026 · 0 likes Post #47 is the version of this I will quote in future. One addition. The most common failure mode is spending fifty minutes on the effect size and ten on the…
-
Retatrutide mass and identity: what a report should show Replied, post #14 · Compounds › Retatrutide · 10 Jul 2026 · 13 likes What I would tell a new member reading about retatrutide mass and identity for the first time: the confident posts are not the reliable ones, and the reliable ones are…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #31 · Practice › Reconstitution · 9 Jul 2026 · 1 like Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #24 · Practice › Interactions · 8 Jul 2026 · 0 likes Post #22 put the caveat in the right place and I want to underline it. Anticoagulant questions come up regularly and are the clearest case for professional advice…
-
Athletes in weight-category sports: a different risk calculus Started this topic · Clinical › Special populations · 21 Jun 2026 · 0 likes Athletes in weight-category sports: a different risk calculus — setting out what I have, and where I think it stops being reliable. Something about athletes in…
-
Does a peptide degrade silently, with no visual change? Replied, post #52 · Practice › Storage & stability · 20 Jun 2026 · 1 like Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Does dual agonism explain the effect size, or is it dose? Replied, post #48 · Compounds › Tirzepatide · 20 Jun 2026 · 4 likes On dual agonism the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #30 · Access › Insurance & coverage · 30 May 2026 · 1 like Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #19 · Practice › Reconstitution · 26 May 2026 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Reconstituting a multi-strength kit, because it is the sort of…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #5 · Access › Pricing · 25 May 2026 · 0 likes I have three months of notes on comparing prices across jurisdictions and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly…
-
The anatomy of a question that gets answered within an hour Replied, post #38 · Start Here › How to Ask · 7 May 2026 · 33 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #90 · Devices › Syringes & needles · 5 May 2026 · 22 likes Where the 0.3 ml versus 0.5 ml discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #16 · Lounge › Introductions · 4 May 2026 · 30 likes Good to have another set of eyes on the wiki posts. Community wiki editing is open at trust level three and the queue of small corrections is permanently longer than…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #35 · Practice › Reconstitution · 3 May 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
-
The best-written scientific paper you have read Replied, post #28 · Lounge › Off topic · 2 May 2026 · 29 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. Reading it again, the caveat matters more than the finding.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #90 · Clinical › Comorbidities · 1 May 2026 · 22 likes Post #87 put the caveat in the right place and I want to underline it. Worth stating the null on type 2 diabetes before we explain it: the observation may be nothing.…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #101 · Compounds › Tirzepatide · 28 Apr 2026 · 7 likes Post #100 is the version of this I will quote in future. One addition. I have been on both sides of the 2.5 mg starting dose argument in this category within eighteen…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #44 · Compounds › Repair & healing peptides · 27 Apr 2026 · 0 likes Answering the question post #40 raises rather than the one it answers. The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is…
-
GLP-1 receptor distribution: central and peripheral Replied, post #39 · Pharmacology › Receptor biology · 27 Apr 2026 · 1 like Post #35 describes the usual case. This is about the unusual one. Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #3 · Compounds › Secretagogues & GH axis · 23 Apr 2026 · 10 likes That matches what I have seen, for whatever a single anecdote is worth.
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #34 · Sourcing › Red flags · 21 Apr 2026 · 7 likes Post #33 put the caveat in the right place and I want to underline it. Being wrong in public about a supplier is costly to that supplier and to the person who was…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #33 · Meta › Announcements · 19 Apr 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Personal import allowances, compared — a second dataset Replied, post #105 · Access › International · 16 Apr 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #16 · Clinical › Comorbidities · 13 Apr 2026 · 0 likes Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable. On reflection I…
-
Follow-up: State-level differences that actually matter Replied, post #78 · Regional › North America · 8 Apr 2026 · 0 likes Date every claim in this subcategory. Positions here have moved repeatedly and old posts are read as current. Caveat: everything above assumes the paperwork is what it…
-
Designing a personal experiment that could change your mind — one year on Replied, post #30 · Research Methods › N-of-1 designs · 7 Apr 2026 · 0 likes Post #28 is the version of this I will quote in future. One addition. Multiple outcomes measured without a primary one means something will move. Nominate the primary…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #67 · Compounds › Tirzepatide · 2 Apr 2026 · 22 likes Speaking only to 2.5 mg starting dose as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests,…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #19 · Practice › Interactions · 1 Apr 2026 · 0 likes Post #18 answers the question as asked. The question underneath it is different. One caution on widely repeated interaction claim: everything above assumes the…
-
Named, unnamed and unspecified impurities as regulatory categories Replied, post #11 · Analytics › Impurities & related substances · 31 Mar 2026 · 0 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Constipation management, with a dietitian's contribution Replied, post #46 · Practice › Side effects · 29 Mar 2026 · 7 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
What a documentation review can and cannot tell you — a second dataset Replied, post #3 · Sourcing › Independent verification · 28 Mar 2026 · 21 likes The opening post describes the usual case. This is about the unusual one. Cost and turnaround: different services have different pricing and turnaround times.…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #52 · Compounds › Tirzepatide · 21 Mar 2026 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #85 · Research Methods › N-of-1 designs · 20 Mar 2026 · 0 likes Measure the same thing the same way at the same time of day. Most of the noise in personal data is measurement protocol rather than biology. The short answer was in the…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #18 · Sourcing › Logistics · 15 Mar 2026 · 7 likes I read post #16 twice before replying, because I had assumed the opposite. Regional warehouse stock versus direct has a well-known answer and a correct answer, and the…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #41 · Access › International · 15 Mar 2026 · 28 likes Something worth flagging about Availability: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #98 · Clinical › Bloodwork · 11 Mar 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #32 · Practice › Reconstitution · 5 Mar 2026 · 0 likes Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.
-
Contributing data without breaching anyone's privacy Replied, post #23 · Data & Tools › Datasets · 3 Mar 2026 · 0 likes Post #22 and I disagree about the size of the effect, not about the direction. State the inclusion criteria explicitly, including the ones you applied without noticing.…
-
The lowest dose that does anything: is that a real question? Replied, post #19 · Practice › Dosing & titration · 2 Mar 2026 · 10 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #34 · Analytics › Impurities & related substances · 24 Feb 2026 · 15 likes Worth stating the null on impurities in solid-phase peptide synthesis before we explain it: the observation may be nothing. That possibility deserves a sentence and…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #18 · Outcomes › Body composition · 21 Feb 2026 · 28 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #54 · Practice › Dosing & titration · 17 Feb 2026 · 6 likes Coming back to post #52, because the follow-up matters more than the original answer. Dose and effect are not linear across the studied range for every compound in this…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #58 · Analytics › Mass spectrometry · 14 Feb 2026 · 0 likes Post #56 put the caveat in the right place and I want to underline it. The practical version of mass error in ppm is three sentences long. The rigorous version is three…
-
Preprint servers and what screening they do Replied, post #52 · Evidence › Preprints · 11 Feb 2026 · 26 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #95 · Access › International · 6 Feb 2026 · 0 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #61 · Documentation › Wiki requests · 29 Jan 2026 · 28 likes Noted, and thank you for writing it out rather than summarising it.
-
Second pass at: What to keep a record of at the point of payment Replied, post #5 · Sourcing › Payments · 25 Jan 2026 · 0 likes The site does not carry prices, payment details or transaction routes, and questions asking for them will be answered with that rather than with a link. I would treat…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #16 · Access › International · 23 Jan 2026 · 17 likes Picking up post #15: that is the part I would want checked first. Language matters for finding primary sources. The authoritative document is usually not in English and…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #81 · Practice › Side effects · 20 Jan 2026 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Realistic expectations for strength while losing weight quickly Replied, post #54 · Nutrition & Training › Resistance training · 17 Jan 2026 · 21 likes Reduced appetite makes fuelling a session harder, and that is a practical problem with practical solutions rather than a reason to stop.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #14 · Outcomes › Body composition · 15 Jan 2026 · 2 likes Post #12 answers the question as asked. The question underneath it is different. Filing a mild objection to the consensus on Lean mass preservation. Mild because I…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #40 · Devices › Pens & autoinjectors · 7 Jan 2026 · 1 like Comparing cost per milligram between a pen and a vial ignores wastage, dead volume and the number of doses actually obtainable. Cost per delivered dose at your dose is…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #44 · Practice › Side effects · 7 Jan 2026 · 4 likes Reported effects on taste and on food preference are common and interesting and unstudied in any detail. They are also the ones people find most disconcerting. Adding…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #97 · Analytics › Home & field testing · 4 Jan 2026 · 1 like A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide.
-
Heterogeneity as information rather than as a nuisance Replied, post #47 · Evidence › Meta-analyses · 2 Jan 2026 · 7 likes Picking up post #44: that is the part I would want checked first. Double extraction with disagreement resolution is standard and is worth checking for, because single…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #34 · Pharmacology › Receptor biology · 30 Dec 2025 · 0 likes Endogenous versus pharmacological receptor engagement differ in magnitude and in duration by orders of magnitude. Arguments from "it is a natural hormone" do not…
-
Aggregates and why a purity assay may miss them entirely Replied, post #12 · Analytics › Impurities & related substances · 16 Dec 2025 · 23 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
The decimal-point error, and the habit that catches it Replied, post #70 · Practice › Reconstitution · 16 Dec 2025 · 17 likes Taking post #69 at face value and following it one step further. I would put moderate confidence on the mainstream reading of decimal-point error and no more. That is…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #93 · Practice › Reconstitution · 10 Dec 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
MHRA statements, read directly Replied, post #43 · Regional › UK & Ireland · 5 Dec 2025 · 1 like Worth separating two things that post #39 runs together. Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable.…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #21 · Compounds › Tirzepatide · 2 Dec 2025 · 5 likes I disagree with the framing of Tirzepatide in type 2 diabetes above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so…
-
Prescription requirements and telehealth models Replied, post #28 · Sourcing › Regulatory · 23 Nov 2025 · 15 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #7 · Practice › Reconstitution · 22 Nov 2025 · 19 likes Working out the concentration after the fact from the volume you added is fine. Working it out from the volume you meant to add is where the errors come from — read the…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #126 · Start Here › How to Ask · 21 Nov 2025 · 26 likes This is the sort of exchange that makes the archive worth searching.
-
Personal import allowances, compared — a second dataset Replied, post #24 · Access › International · 19 Nov 2025 · 4 likes Reading this Personal import allowances thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Publishing an inconvenient result: a case study — the long version Replied, post #31 · Sourcing › Independent verification · 8 Nov 2025 · 14 likes Publishing an inconvenient result would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #4 · Compounds › Tirzepatide · 5 Nov 2025 · 5 likes The opening post answers the question as asked. The question underneath it is different. Tirzepatide's half-life of roughly five days means steady state is approached…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #87 · Documentation › Doc review · 4 Nov 2025 · 1 like Objections are genuinely wanted at this stage, because a bad promotion is much harder to undo than a bad reply. I am reporting what happened, not recommending it.
-
Follow-up: Why appetite effects are mostly central Replied, post #71 · Pharmacology › Receptor biology · 19 Oct 2025 · 2 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #74 · Compounds › Semaglutide · 12 Oct 2025 · 10 likes Right, and stated more narrowly than I would have dared to state it.
-
Comparing two chromatograms from different laboratories, properly Replied, post #16 · Analytics › HPLC & UHPLC · 2 Oct 2025 · 0 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Why the timeline is on the right and not the left Replied, post #71 · Meta › Site feedback · 20 Sep 2025 · 1 like Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation so staff can clarify or reconsider. The step people…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #76 · Practice › Side effects · 19 Sep 2025 · 13 likes The reason nausea timeline is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
-
Column chemistry choices for a 40-residue peptide Replied, post #39 · Analytics › HPLC & UHPLC · 18 Sep 2025 · 28 likes Answering the column chemistry choices question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how…
-
Discussing something you have already been doing Replied, post #3 · Clinical › Prescriber conversations · 9 Sep 2025 · 0 likes Picking up the opening post: that is the part I would want checked first. A question phrased as "what would you want to see before considering X" is answerable and is…
-
Liver enzymes drifting down and what that usually means Replied, post #8 · marked as the solution · Clinical › Bloodwork · 31 Aug 2025 · 23 likes Since liver enzymes drifting keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
A request that was declined, and the reasoning — a second dataset Replied, post #91 · Documentation › Wiki requests · 15 Aug 2025 · 30 likes Say what would make the page wrong. A page whose failure conditions are stated is much easier to review honestly. I would put the burden of proof on the interesting…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #101 · Compounds › Repair & healing peptides · 13 Aug 2025 · 0 likes TB-500 is a fragment rather than the whole thymosin beta-4 protein, and the two are used interchangeably in product descriptions when they should not be. The fragment…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #5 · Analytics › Method validation · 31 Jul 2025 · 1 like The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. A weak preference rather than a…
-
Sodium, potassium and magnesium when intake drops Replied, post #65 · Nutrition & Training › Hydration & electrolytes · 18 Jul 2025 · 1 like Sodium has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Specification in the result column: why that is a meaningful error Replied, post #19 · Analytics › COA interpretation · 15 Jul 2025 · 29 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #74 · Outcomes › Progress reports · 2 Jul 2025 · 33 likes Photographs at fixed intervals under fixed conditions are a better record of composition change than the scale, and much harder to standardise.
-
Coming back to: When "no data" is the complete and final answer Replied, post #29 · Compounds › Other compounds · 30 Jun 2025 · 9 likes I had written a reply contradicting post #25 and deleted it. Here is what survived. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #120 · Clinical › Comorbidities · 20 Jun 2025 · 0 likes Second this, and I would have said it less carefully.
-
Counter-ion content and its effect on measured mass Replied, post #61 · Analytics › Mass spectrometry · 10 Jun 2025 · 2 likes Picking up post #60: that is the part I would want checked first. Deamidation adds approximately one dalton and produces a species that frequently elutes very close to…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #116 · Practice › Interactions · 5 Jun 2025 · 7 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #9 · Sourcing › Vendor reports · 5 Jun 2025 · 23 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. That is the version I use. It may not be…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #114 · Data & Tools › Calculators · 5 Jun 2025 · 30 likes Second this, and I would have said it less carefully.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #122 · Access › Pricing · 1 Jun 2025 · 2 likes Independent testing is a real cost and belongs in the comparison. A cheaper supplier tested every lot may cost more in total. On balance I think that is right, and I…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #5 · Devices › Pens & autoinjectors · 29 May 2025 · 0 likes That is a fair summary of where the discussion has got to.
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #7 · Compounds › Semaglutide · 26 May 2025 · 0 likes Offering a way to settle semaglutide versus liraglutide rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #28 · Sourcing › Vendor reports · 17 May 2025 · 6 likes Confirming post #25 from a second method, which matters more than confirming it from a second person. The cost of a submission is worth stating. It is the main reason…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #94 · Sourcing › Red flags · 12 May 2025 · 0 likes Adding the measurement that post #92 says would settle it. The strongest single signal available cheaply is what happens when you ask a technical question. A…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #96 · Devices › Cold chain · 3 May 2025 · 5 likes Coming back to post #95, because the follow-up matters more than the original answer. A temperature indicator that has tripped tells you a threshold was crossed. It…
-
When "no data" is the complete and final answer Replied, post #164 · Compounds › Other compounds · 30 Apr 2025 · 12 likes Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #4 · marked as the solution · Compounds › Retatrutide · 26 Apr 2025 · 7 likes The evidence status here should be stated in the first line of any post about it rather than the last. Everything is phase 2 or earlier, and a reader arriving from a…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #13 · Evidence › Trials · 18 Apr 2025 · 6 likes Narrowing post #12, because the general version has more than one answer. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #17 · Evidence › Journal club · 17 Apr 2025 · 12 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Retatrutide dose escalation in the published trials Replied, post #76 · Compounds › Retatrutide · 1 Apr 2025 · 0 likes Building on post #74 rather than restating it. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no…
-
Coverage for the indication versus for the drug Replied, post #14 · Access › Insurance & coverage · 30 Mar 2025 · 12 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #91 · Sourcing › Vendor reports · 17 Mar 2025 · 7 likes Where you submitted more than one vial from a consignment, say so. Intra-consignment comparison is one of the more useful things an individual can contribute.
-
Reading order for a first week here, and what to skip until later Replied, post #38 · Start Here › Welcome · 15 Mar 2025 · 0 likes I would call the community position on reading order likely rather than established, and I would be comfortable defending that hedge.
-
Validating a method you did not develop — does this still hold? Replied, post #112 · Analytics › Method validation · 14 Mar 2025 · 0 likes Linearity across the working range is a routine demonstration and it constrains how far a result can be extrapolated. A method linear from 80 to 120 per cent of nominal…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #52 · Sourcing › Regulatory · 1 Mar 2025 · 0 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence. It is worth stating the…
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #17 · Analytics › Mass spectrometry · 25 Feb 2025 · 1 like Response in electrospray is not proportional to abundance across different species. Using peak intensities from a mass spectrum to estimate proportions is a mistake…
-
Scheduled maintenance and what will be unavailable Replied, post #51 · Meta › Announcements · 22 Feb 2025 · 23 likes I would keep scheduled maintenance and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #89 · Sourcing › Regulatory · 20 Feb 2025 · 32 likes That is clearer than the version I had in my head. Thank you.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #14 · Access › Pricing · 20 Feb 2025 · 24 likes The cost of an independent submission is worth stating in these threads, because it is the main reason people do not do it. Happy to be the one who is wrong here if it…
-
Coming back to: Official shortage notices and what they authorise Replied, post #20 · Access › Shortages · 15 Feb 2025 · 7 likes Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is frustrating and is not evidence of anything. This has been…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #3 · Practice › Administration · 4 Feb 2025 · 29 likes Building on the opening post rather than restating it. A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #15 · Analytics › COA interpretation · 17 Jan 2025 · 11 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Recovery when intake is low: what to cut first Replied, post #81 · Nutrition & Training › Resistance training · 14 Jan 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Oxidation pathways for methionine and tryptophan Replied, post #22 · Analytics › Impurities & related substances · 27 Dec 2024 · 23 likes Scavengers and cleavage-cocktail residues can persist and appear as small early-eluting peaks. They are process-related rather than sequence-related, which is a useful…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #22 · Compounds › Repair & healing peptides · 22 Dec 2024 · 2 likes A definition problem is doing most of the work in this TB-500 and thymosin beta-4 discussion. Once the term is pinned down I suspect the disagreement mostly goes away…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #51 · Compounds › Semaglutide · 22 Dec 2024 · 17 likes Noted, and thank you for writing it out rather than summarising it.
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #29 · Meta › Wiki maintenance · 7 Nov 2024 · 32 likes This follows post #28 rather than contradicting it. Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is…
-
The topic list is dense — is that deliberate? Replied, post #41 · Meta › Site feedback · 21 Oct 2024 · 0 likes Post #40 is the version of this I will quote in future. One addition. Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #66 · Clinical › Prescriber conversations · 28 Sep 2024 · 16 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #9 · Practice › Interactions · 18 Sep 2024 · 0 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. That is the…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #16 · Compounds › Oral incretins · 30 Aug 2024 · 0 likes Post #13 answers the question as asked. The question underneath it is different. Timing consistency matters more for oral dosing than for weekly injection, because…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #14 · Compounds › Oral incretins · 28 Aug 2024 · 32 likes This follows post #11 rather than contradicting it. My understanding of orforglipron is a few years old and may have been superseded. If it has been, I would genuinely…
-
Correlation in a self-tracked dataset: what it can support Replied, post #7 · Research Methods › Statistics · 20 Aug 2024 · 31 likes P-values and significance: p Two sources, same conclusion, and I could not rule out that one copied the other.
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #5 · Analytics › Method validation · 2 Aug 2024 · 0 likes Two claims get bundled together under Relative retention time and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #44 · Practice › Dosing & titration · 10 Jul 2024 · 5 likes No notes. Posting so the count is not one.
-
Journal club: FLOW and the renal composite, component by component Replied, post #10 · Evidence › Journal club · 9 Jul 2024 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping. I…